Ghost Tree Capital, LLC Catalyst Biosciences, Inc. Transaction History

Ghost Tree Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 16, 2022	SELL	$0.91 - $4.16 $910,000 - $4.16 Million	-1,000,000 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$4.93 - $7.15 $4.93 Million - $7.15 Million	1,000,000 New	1,000,000 $5.04 Million
Q2 2019 Aug 14, 2019	SELL	$7.08 - $10.6 $708,000 - $1.06 Million	-100,000 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$7.67 - $9.96 $767,000 - $996,000	-100,000 Reduced 50.0%	100,000 $811,000
Q3 2018 Nov 14, 2018	SELL	$9.35 - $12.44 $1.45 Million - $1.93 Million	-155,000 Reduced 43.66%	200,000 $2.16 Million
Q2 2018 Aug 14, 2018	SELL	$9.11 - $28.88 $865,450 - $2.74 Million	-95,000 Reduced 21.11%	355,000 $4.14 Million
Q1 2018 May 15, 2018	BUY	$14.18 - $35.6 $6.38 Million - $16 Million	450,000 New	450,000 $11.6 Million

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.